Is Palantir Stock Overhyped?
At one point, it seemed like the software giant Palantir…
Sell
26
FTXH Quote, Financials, Valuation and Earnings
Last price:
$28.39
Seasonality move
:
-1.04%
Day range:
$27.86 - $27.96
52-week range:
$25.73 - $29.72
Dividend yield:
1.61%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
1.2K
Avg. volume:
3.9K
1-year change:
-1.69%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, First Trust Nasdaq Pharmaceuticals ETF has -- downside to fair value with a price target of -- per share.
FTXH vs. S&P 500
-
Over the past 5 trading days, First Trust Nasdaq Pharmaceuticals ETF has overperformed the S&P 500 by 2.54% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
First Trust Nasdaq Pharmaceuticals ETF does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
First Trust Nasdaq Pharmaceuticals ETF has grown year-over-year revenues for 0 quarters straight. In the most recent quarter First Trust Nasdaq Pharmaceuticals ETF reported revenues of --.
Earnings Growth
-
First Trust Nasdaq Pharmaceuticals ETF has grown year-over-year earnings for 0 quarters straight. In the most recent quarter First Trust Nasdaq Pharmaceuticals ETF reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-01 | 2024-03-01 | 2024-03-01 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2021-03-01 | 2022-03-01 | 2023-03-01 | 2024-03-01 | ||
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | -- | -- | -- | |
| Current Liabilities | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-01 | 2024-03-01 | 2024-03-01 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
FTXH
Sector
Market Cap
--
--
Price % of 52-Week High
93.75%
--
Dividend Yield
1.61%
--
Shareholder Yield
--
--
1-Year Price Total Return
-1.69%
--
Beta (5-Year)
0.664
--
Dividend yield:
1.61%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$27.94
200-day SMA
Buy
Level
$27.94
Bollinger Bands (100)
Buy
Level
27.25 - 28.51
Chaikin Money Flow
Sell
Level
-893.7K
20-day SMA
Buy
Level
$27.71
Relative Strength Index (RSI14)
Buy
Level
53.25
ADX Line
Buy
Level
17.14
Williams %R
Neutral
Level
-40.4465
50-day SMA
Buy
Level
$27.42
MACD (12, 26)
Buy
Level
0.17
25-day Aroon Oscillator
Buy
Level
20
On Balance Volume
Sell
Level
-510.6K
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (6)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Stock Forecast FAQ
In the current month, FTXH has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The FTXH average analyst price target in the past 3 months is --.
-
Where Will First Trust Nasdaq Pharmaceuticals ETF Stock Be In 1 Year?
According to analysts, the consensus estimate is that First Trust Nasdaq Pharmaceuticals ETF share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About First Trust Nasdaq Pharmaceuticals ETF?
Analysts are divided on their view about First Trust Nasdaq Pharmaceuticals ETF share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that First Trust Nasdaq Pharmaceuticals ETF is a Sell and believe this share price will rise from its current level to --.
-
What Is First Trust Nasdaq Pharmaceuticals ETF's Price Target?
The price target for First Trust Nasdaq Pharmaceuticals ETF over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is FTXH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for First Trust Nasdaq Pharmaceuticals ETF is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of FTXH?
You can purchase shares of First Trust Nasdaq Pharmaceuticals ETF via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase First Trust Nasdaq Pharmaceuticals ETF shares.
-
What Is The First Trust Nasdaq Pharmaceuticals ETF Share Price Today?
First Trust Nasdaq Pharmaceuticals ETF was last trading at $28.39 per share. This represents the most recent stock quote for First Trust Nasdaq Pharmaceuticals ETF. Yesterday, First Trust Nasdaq Pharmaceuticals ETF closed at $28.24 per share.
-
How To Buy First Trust Nasdaq Pharmaceuticals ETF Stock Online?
In order to purchase First Trust Nasdaq Pharmaceuticals ETF stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Texas Roadhouse a Buy, Sell or Hold?
Texas Roadhouse (NASDAQ:TXRH) is a popular chain of steakhouses with…
New Billion Dollar Contract Surprises GEO Analysts
While earnings appeared mixed at first glance, management’s comments on…
Stock Ideas
Buy
61
Is AAPL Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 40x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Sell
22
ACHC alert for Mar 1
Acadia Healthcare [ACHC] is down 25.48% over the past day.
Buy
63
ROOT alert for Feb 28
Root [ROOT] is up 9.09% over the past day.
Buy
75
GRRR alert for Mar 1
Gorilla Technology Group [GRRR] is up 21.83% over the past day.
